Purchase Order 75N92023P00325

Award Date 8/23/23
Potential Completion Date 9/23/23
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $57,031.60 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to Meso Scale Diagnostics LLC (also doing business as Meso Scale Discovery). The contract is for MESO SCALE DISCOVERY ASSAYS with a period of performance through June 25, 2025. Meso Scale Diagnostics is a for-profit limited liability company that specializes in assay development, laboratory testing...
This contract award to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, is for the procurement of a custom U-Plex biomarker set from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. The firm fixed price contract has a potential value of $148,989.10 and a completion date of November 1, 2021. It supports the Coronavirus COVID-19 national interest action. Meso Scale Diagnostics is a for-profit limited liability...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $10,326.95 firm-fixed-price purchase order contract to Meso Scale Diagnostics, LLC (doing business as Meso Scale Discovery) to supply MSD kits for running high-throughput detection and quantification of neutrophil biomarkers to support a dengue study. This contract has no set-aside designation and is for completion by April 7, 2025. Meso Scale Diagnostics is...
Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, has been awarded a $13,000 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This contract is for the Meso QuickPlex SQ 120 Total Service Package, to be delivered to Hamilton, Montana by March 31, 2025. Meso Scale Discovery will provide the assay development services, laboratory testing equipment, immunoassays,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $67,504.25 firm fixed price purchase order to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, to provide assay plates supplies and qualification services in support of medical research efforts. As the prime contractor, Meso Scale Diagnostics will deliver assay plates and conduct associated qualification testing at its place of...
Meso Scale Diagnostics, LLC, doing business as Meso Scale Discovery, has been awarded a $4,900 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide products or services in support of the agency's research programs. As the prime contractor, Meso Scale Discovery will perform the work itself under the contract, which runs from May 2018 through June 2019. The funding agency, HHS's NIH branch, supports biomedical...
Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, has been awarded a $24,093.95 firm fixed price purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide ELISA/ASSAY PANEL KITS (S-PLEX, U-PLEX, V-PLEX, R-PLEX) in support of the agency's biomedical research efforts. Performance will take place in Potomac, Maryland over a two month period concluding in late September 2023. No subcontractors or set aside...
Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, has been awarded a firm-fixed price purchase order for $31,150 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This award is to provide a one year service agreement for maintenance and support of a Meso Sector S 600 instrument, including a Windows 10 upgrade, at the agency's location in Potomac, Maryland. The solicitation had requested quotes...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, a for-profit limited liability company. The award, valued at $29,184.25, is for MESO SCALE DIAGNOSTICS MULTI ARRAY AND U-PLEX PLATES with a completion date of July 26, 2024. Meso Scale Diagnostics is a key supplier of assay development services,...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. The $9,002.30 contract is for the delivery of biomarker and assay kits. Meso Scale Diagnostics is a for-profit limited liability company that specializes in assay development, laboratory testing equipment, immunoassays, and...

The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a firm fixed price purchase order valued at $24,707 to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery. Under this contract, Meso Scale Discovery will provide multiplex kits to support the Heart Disease Phenomics Laboratory's stated need to measure 10 biomarkers associated with heart failure using Meso Scale Discovery's multiplex platform. Performance will take place in Potomac, Maryland over a period of one month concluding in September 2023. No subcontractors or set aside designations were identified. This supports the National Institutes of Health's broader biomedical research efforts to advance understanding of heart disease.

Generated 12/20/23, 1:26 PM